Bridging the Gap Between Participants and Clinical Trials
HB-PTSD-001: Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study
CONDITION
Mental Health
GENDER
AGE GROUP
From 18
to 65 years
STATUS
Not yet recruiting
Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double Blind, Placebo-Controlled Study
Studies Contact Form
Approved By: Bellberry
Clinical Trial Registry Link:
Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260